CANTA, ANNALISA ROSANNA
 Distribuzione geografica
Continente #
NA - Nord America 9.679
EU - Europa 5.384
AS - Asia 1.715
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 15
SA - Sud America 13
Totale 16.855
Nazione #
US - Stati Uniti d'America 9.494
DE - Germania 1.241
SE - Svezia 952
CN - Cina 948
IT - Italia 923
IE - Irlanda 828
UA - Ucraina 503
GB - Regno Unito 299
HK - Hong Kong 269
CA - Canada 182
VN - Vietnam 150
FI - Finlandia 143
AT - Austria 118
IN - India 94
FR - Francia 92
RU - Federazione Russa 86
DK - Danimarca 69
KR - Corea 65
JP - Giappone 56
TR - Turchia 38
SG - Singapore 36
BE - Belgio 33
NL - Olanda 30
EU - Europa 20
IR - Iran 20
PL - Polonia 20
NZ - Nuova Zelanda 15
AU - Australia 11
BR - Brasile 11
RO - Romania 11
EG - Egitto 9
HR - Croazia 8
MY - Malesia 8
TW - Taiwan 7
BG - Bulgaria 6
PT - Portogallo 6
ES - Italia 5
IL - Israele 5
CH - Svizzera 4
PK - Pakistan 4
IQ - Iraq 3
LB - Libano 3
RS - Serbia 3
ZA - Sudafrica 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
ID - Indonesia 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
MA - Marocco 1
MD - Moldavia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 16.855
Città #
Ann Arbor 2.459
Woodbridge 853
Dublin 810
Chandler 808
Frankfurt am Main 698
Houston 609
Wilmington 545
Jacksonville 534
Fairfield 480
Dearborn 436
Milan 381
Ashburn 378
New York 344
Princeton 282
Hong Kong 253
Seattle 211
Nanjing 183
Cambridge 141
Vienna 118
Shanghai 115
Beijing 92
Lachine 84
Guangzhou 81
Lawrence 80
Boardman 79
Dong Ket 77
Altamura 74
Nanchang 59
Shenyang 56
Andover 49
Helsinki 49
Grafing 45
Falls Church 42
Toronto 41
Fremont 40
San Diego 38
Carate Brianza 35
Nürnberg 35
Pune 34
Jinan 33
Jiaxing 32
Brussels 31
Kunming 28
Los Angeles 28
Tianjin 28
Ottawa 27
Norwalk 26
Changsha 25
Daejeon 24
Hangzhou 23
Mountain View 22
Sacramento 22
Shangdi 22
Zhengzhou 22
London 19
Bergamo 18
Hebei 18
Codroipo 17
Tokyo 16
Hefei 15
Ningbo 15
Chicago 14
Leawood 14
Lissone 14
Mainz 14
Edmonton 13
Huizen 13
Kraków 12
Shinjuku 12
Taizhou 12
Auburn Hills 11
San Mateo 11
Sesto San Giovanni 11
Washington 11
Kiev 10
Phoenix 9
Seoul 9
Rome 8
Wuhan 8
Bologna 7
Kuala Lumpur 7
Paris 7
Ahmedabad 6
Ardabil 6
Cagliari 6
Detroit 6
Frederick 6
Fuzhou 6
Laurel 6
Monmouth Junction 6
Paderno Dugnano 6
Somma Lombardo 6
Suwon 6
Duncan 5
Haikou 5
Lanzhou 5
Lappeenranta 5
Menlo Park 5
Merate 5
Monza 5
Totale 12.567
Nome #
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 321
Age-related changes in the function and structure of the peripheral sensory pathway in mice 286
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 253
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 222
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 202
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 194
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 190
Enhanced brain targeting of engineered solid lipid nanoparticles 189
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 188
Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain 185
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 178
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 177
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 172
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 170
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 169
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 168
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 165
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 164
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 162
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 161
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 161
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 161
A large-field polarisation-resolved laser scanning microscope: Applications to CARS imaging 160
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 158
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 157
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 157
Enhanced brain targeting of engineered solid lipid nanoparticles 155
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 153
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 152
Effects of different erythropoietin schedules in cisplatin-induced peripheral neurotoxicity 151
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 151
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 151
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 150
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 150
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 149
The neuroprotective effect of erythropoietin (EPO) and of its non-erythropoietic carbamylated derivative (CEPO) in cisplatin-induced peripheral neurotoxicity 146
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 146
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 144
OCT2 transporter involvement in development of cisplatin toxicity 143
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 142
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 142
Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation 141
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 140
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 139
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 138
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 138
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 134
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 134
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 134
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 134
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 131
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 130
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 130
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 129
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 126
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 125
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 123
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 122
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 122
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 121
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 119
Multimodal experimental approach to the study of human neurological diseases 118
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 118
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 116
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 115
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 114
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 112
Chemotherapy-induced allodinia: Neuroprotective effect of acetyl-L-carnitine 109
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 109
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 109
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 108
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 107
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 107
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 107
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 106
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 104
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 103
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 103
Effect of proteasome inhibition on the central and peripheral nervous system 103
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 103
Genetic factors influencing the development of vincristine-induced neurotoxicity 103
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 102
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 102
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 101
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 101
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 101
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 101
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 101
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 101
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 97
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 97
EVALUATION OF THE CONTINUOUS BUPRENORPHINE DELIVERY ANALGESIC EFFECT IN AN EXPERIMENTAL RAT MODEL OF PAINFUL DIABETIC NEUROPATHY 94
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 93
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 91
Totale 14.357
Categoria #
all - tutte 50.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019515 0 0 0 0 0 0 0 0 0 0 206 309
2019/20203.019 369 153 214 189 273 389 480 175 266 254 212 45
2020/20212.832 140 129 318 276 235 254 314 247 241 217 178 283
2021/20221.893 132 194 143 200 168 212 91 89 91 133 144 296
2022/20233.477 363 887 321 358 276 535 61 176 277 56 103 64
2023/20242.386 97 106 106 134 345 709 512 171 134 65 7 0
Totale 17.879